ID: ALA276375

Max Phase: Preclinical

Molecular Formula: C13H17N

Molecular Weight: 187.29

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC=C=CCN(C)Cc1ccccc1

Standard InChI:  InChI=1S/C13H17N/c1-3-4-8-11-14(2)12-13-9-6-5-7-10-13/h3,5-10H,11-12H2,1-2H3

Standard InChI Key:  XVHFYIVMBDAHOJ-UHFFFAOYSA-N

Associated Targets(non-human)

Monoamine oxidase 439 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Monoamine oxidase 94 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Monoamine oxidase B 346 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 187.29Molecular Weight (Monoisotopic): 187.1361AlogP: 2.85#Rotatable Bonds: 4
Polar Surface Area: 3.24Molecular Species: NEUTRALHBA: 1HBD: 0
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.06CX LogP: 3.27CX LogD: 2.52
Aromatic Rings: 1Heavy Atoms: 14QED Weighted: 0.66Np Likeness Score: -0.46

References

1. Sahlberg C, Ross SB, Fagervall I, Ask AL, Claesson A..  (1983)  Synthesis and monoamine oxidase inhibitory activities of alpha-allenic amines in vivo and in vitro. Different activities of two enantiomeric allenes.,  26  (7): [PMID:6864731] [10.1021/jm00361a017]

Source